Sonogen Medical is working to commercialize a ground-breaking ultrasonic bone growth stimulation device that optimizes bone fracture healing while providing real-time feedback on both patient compliance and the fracture healing process.
Primary Application Area: Medical Devices & Materials
Technology Development Status: Prototype
Technology Readiness Level: TRL 3
Vetted Programs/Awards: Sonogen was a winner of the Medical Innovation Challenge at 2022 Defense TechConnect -- the single premier DoD MedTech conference in the United States. The results of Sonogen's proof of concept animal study was peer reviewed and published in the IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control.
Organization Type: Early-stage Startup (Seed)
Market Keywords: Diagnostics, Therapeutics, Fracture Healing